+276.1%
EBAY vs GSK
+80.1%
+196.0%
-53.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | +2.6% | 0.0% | +2.6% | +2.6% |
| 7D | +4.2% | -3.5% | +7.7% | +5.1% |
| 30D | +5.6% | -3.4% | +9.1% | +6.5% |
| 3M | -1.4% | -8.1% | +6.7% | +0.6% |
| 6M | +18.2% | -11.1% | +29.3% | +21.3% |
| YTD | +24.8% | +0.7% | +24.1% | +23.4% |
| 1Y | +18.0% | +20.1% | -2.1% | +10.3% |
| 3Y | +160.3% | +46.1% | +114.1% | +124.4% |
| 5Y | +62.1% | +48.2% | +13.9% | +36.0% |
| All | +276.1% | +80.1% | +196.0% | +189.2% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling